AI Verdict
GSBD has stronger fundamentals based on our AI analysis.
GSBD vs GRVE Fundamental Comparison
| Metric | GSBD | GRVE |
|---|---|---|
| Revenue | N/A | $-8,614.0 |
| Net Income | $119.3M | $-104,420.0 |
| Net Margin | N/A | 1,212.2% |
| ROE | 8.4% | N/A |
| ROA | 3.5% | -1,668.1% |
| Current Ratio | N/A | 0.00x |
| Debt/Equity | 1.32x | N/A |
| EPS | $1.03 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GSBD vs GRVE: Frequently Asked Questions
Is GSBD or GRVE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GSBD has stronger fundamentals. GSBD is rated HOLD (68% confidence) while GRVE is rated STRONG SELL (92% confidence). This is not investment advice.
How does GSBD compare to GRVE fundamentally?
Goldman Sachs BDC, Inc. has ROE of 8.4% vs GROOVE BOTANICALS INC.'s N/A. Net margins are N/A vs 1,212.2% respectively.
Which stock pays higher dividends, GSBD or GRVE?
GSBD has a dividend yield of N/A or no dividend while GRVE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GSBD or GRVE for long term?
For long-term investing, consider that GSBD has HOLD rating with 68% confidence, while GRVE has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GSBD vs GRVE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GSBD vs GRVE, the AI consensus favors GSBD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.